Synthesis, molecular docking and antibacterial evaluation of 2-(4-(4-aminophenylsulfonyl)phenylamino)-3-(thiophen-2-ylthio)naphthalene-1,4-dione derivatives

Palanisamy RAVICHANDIRAN, Dhanaraj PREMNATH, Samuel VASANTHKUMAR

PDF(608 KB)
PDF(608 KB)
Front. Chem. Sci. Eng. ›› 2015, Vol. 9 ›› Issue (1) : 46-56. DOI: 10.1007/s11705-015-1506-6
RESEARCH ARTICLE
RESEARCH ARTICLE

Synthesis, molecular docking and antibacterial evaluation of 2-(4-(4-aminophenylsulfonyl)phenylamino)-3-(thiophen-2-ylthio)naphthalene-1,4-dione derivatives

Author information +
History +

Abstract

A new series of 2-(4-(4-aminophenylsulfonyl)phenylamino)-3-(thiophen-2-ylthio)naphthalene-1,4-dione derivatives (3a-3n) were synthesized and characterized by spectral techniques. To understand the interaction of binding sites with bacterial protein receptor, the docking study was performed by the GLIDE program and compound N-(4-(4-(1,4-dioxo-3-(thiophen-2-ylthio)-1,4-dihydronaphthalen-2-ylamino)phenylsulfonyl)phenyl)-3-methylbenzamide (3b) exhibited good glide and E model scores of ‒5.89 and ‒94.90, respectively. Moreover among all the molecules studied including the standards used, namely Sparfloxacin (4.8 µg/mL) and Norfloxacin (no inhibition observed) for their antibacterial property, compound N-(4-(4-(1,4-dioxo-3-(thiophen-2-ylthio)-1,4-dihydronaphthalen-2-ylamino)phenylsulfonyl)phenyl)-4-nitrobenzamide (3e) exhibited the lowest minimum inhibitory concentration (MIC) value of 1.3 µg/mL against Proteus vulgaris.

Graphical abstract

Keywords

MIC / 2-thiophene thiol / water as solvent / acid chlorides / sulfone

Cite this article

Download citation ▾
Palanisamy RAVICHANDIRAN, Dhanaraj PREMNATH, Samuel VASANTHKUMAR. Synthesis, molecular docking and antibacterial evaluation of 2-(4-(4-aminophenylsulfonyl)phenylamino)-3-(thiophen-2-ylthio)naphthalene-1,4-dione derivatives. Front. Chem. Sci. Eng., 2015, 9(1): 46‒56 https://doi.org/10.1007/s11705-015-1506-6

References

[1]
Hussain H, Krohn K, Ahmad V U, Miana G A, Green I R. Lapachol: An overview. ARKIVOC, 2007, 2007(2): 145–171
[2]
Tandon V K, Maurya H K, Tripathi A, Keshava G B S, Shukla P K, Srivastava P, Panda D. 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: Synthesis and biological evaluation as potential antiproliferative and antifungal agents. European Journal of Medicinal Chemistry, 2009, 44(3): 1086–1092
[3]
Liu K C, Li J, Sakya S. Mini Reviews in Medicinal Chemistry, 2004, 4(10): 1105–1125
[4]
Pe’rez-Sacau E, Este’vez-Braun A, Ravelo A G, Ferro E A, Tokuda H, Mukainaka T, Nishino H. Inhibitory effects of lapachol derivatives on epstein-barr virus activation. Bioorganic & Medicinal Chemistry, 2003, 11(4): 483–488
[5]
Silva T M S, Camara C S, Barbosa T P, Soares A Z, Cunha L C, Pinto A C, Vargas M D. Molluscicidal activity of synthetic lapachol amino and hydrogenated derivatives. Bioorganic & Medicinal Chemistry, 2005, 13(1): 193–196
[6]
Lien J C, Huang L J, Wang J P, Teng C M, Lee K H, Kuo S C. Synthesis and antiplatelet, antiinflammatory and antiallergic activities of 2,3-Disubstituted 1,4-Naphthoquinones. Chemical & Pharmaceutical Bulletin, 1996, 44(6): 1181–1187
[7]
Biot C, Bauer H, Schirmer R H, Charret E D. 5-Substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials. Journal of Medicinal Chemistry, 2004, 47(24): 5972–5983
[8]
Mantyla A, Rautio J T G, Nevalainen T, Vepsalainen J, Koskinen A, Croft S I, Jarvinen T. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone. Journal of Medicinal Chemistry, 2004, 47(1): 188–195
[9]
Tandon V K, Yadav D B, Singh R V, Chaturvedi A K, Shukla P K. Synthesis and biological evaluation of novel (l)-α-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents. Bioorganic & Medicinal Chemistry Letters, 2005, 15(23): 5324–5328
[10]
Tandon V K, Yadav D B, Maurya H K, Chaturvedi A K, Shukla P K. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents. Bioorganic & Medicinal Chemistry, 2006, 14(17): 6120–6126
[11]
Shchekotikhin A E, Buyanov V N, Preobrazhenskaya M N. Synthesis of 1-(ω-aminoalkyl)naphthoindolediones with antiproliferative properties. Bioorganic & Medicinal Chemistry, 2004, 12(14): 3923–3930
[12]
Ravichandiran P, Jegan A, Premnath D, Periyasamy V S, Muthusubramanian S, Vasanthkumar S. Synthesis, molecular docking and cytotoxicity evaluation of novel 2-(4-amino-benzosulfonyl)-5H-benzo[b]carbazole-6,11-dione derivatives as histone deacetylase (HDAC8) inhibitors. Bioorganic Chemistry, 2014, 53: 24–36
[13]
Ravichandiran P, Kannan R, Ramasubbu A, Muthusubramanian S, Samuel V K. Green synthesis of 1,4-quinone derivatives and evaluation of their fluorescent and electro chemical properties. Journal of Saudi Chemical Society, 2012,
CrossRef Google scholar
[14]
Carroll F I, Dudley K H, Miller H W. Preparation of some sulfonamide and diaminodiphenyl sulfone analogs of 1,4-naphthoquinone. Journal of Medicinal Chemistry, 1969, 12(1): 187–189
[15]
Someya T, Baba S, Fujimoto M, Kawai G, Kumasaka T, Nakamura K. Crystal structure of ymaH (Hfq) from Bacillus subtilis in complex with an RNA aptamer. Nucleic Acids Research, 2012, 40(4): 1856–1867
[16]
Huang W, Lunin V V, Li Y, Suzuki S, Sugiura N, Miyazono H, Cygler M. Crystal structure of chondroitin ABC lyase I from proteus vulgaris at 1.9 angstroms resolution. Journal of Molecular Biology, 2003, 328(3): 623–634
[17]
Friesner R A O, Murphy R B, Repasky M P, Frye L L, Greenwood J R, Halgren T A, Sanschagrin P C, Mainzet D T. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 2006, 49(21): 6177–6196
[18]
Baron E J, Finegold S M. In Bailey and Scott’s Diagnostic Microbiology, 8th ed; C.V. Mosby: St. Louis, 1990, 184–188
[19]
Massah A R, Adibi H, Khodarahmi R, Abiri R, Majnooni M B, Shahidi S, Asadi B, Mehrabi M, Zolfigol M A. T. Synthesis, in vitro antibacterial and carbonic anhydrase II inhibitory activities of N-acylsulfonamides using silica sulfuric acid as an efficient catalyst under both solvent-free and heterogeneous conditions. Bioorganic & Medicinal Chemistry, 2008, 16(10): 5465–5472
[20]
Andrews J M J. Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 2001, 48(1): 5–16
[21]
Bissinger E M, Heinke R, Spannhoff A, Eberlin A, Metzger E, Cura V, Hassenboehler P, Cavarelli J, Schüle R, Bedford M T, Sippl W, Jung M. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorganic & Medicinal Chemistry, 2011, 19(12): 3717–3731
[22]
Tandon V K, Maurya H K, Verma M K, Kumar R, Shukla P K. ‘On water’ assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. European Journal of Medicinal Chemistry, 2010, 45(6): 2418–2426
[23]
Tandon V K, Maurya H K, Mishra N N, Shukla P K. Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. European Journal of Medicinal Chemistry, 2009, 44(8): 3130–3137
[24]
Ravichandiran P, Premnath D, Vasanthkumar S. Synthesis, molecular docking and antibacterial evaluation of new 1,4-naphthoquinone derivatives contains carbazole-6,11-dione moiety. Journal of Chemical Biology, 2014, 7(3): 93–101
[25]
Ravichandiran P, Jegan A, Premnath D, Periasamy V S, Vasanthkumar S. Design, synthesis, molecular docking as histone deacetylase (HDAC8) inhibitors, cytotoxicity and antibacterial evaluation of novel 6-(4-(4-aminophenylsulfonyl)phenylamino)-5H-benzo[a]phenoxazin-5-one derivatives. Medicinal Chemistry Research, 2015, 24(1): 197–208
[26]
Ravichandiran P, Jegan A, Premnath D, Periasamy V S, Alshatwi A A, Vasanthkumar S. Synthesis, molecular docking and biological evaluation of novel 6-(4-(4-aminophenylsulfonyl)phenylamino)-5H-benzo[a]phenothiazin-5-one derivatives. Spectrochimica Acta. Part A: Molecular and Biomolecular Spectroscopy, 2015, 139: 477–487
[27]
National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast, Approved Standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, USA, 1997
[28]
National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium Forming Filamentous Fungi: Proposed Standard. Document M38-P. National Committee for Clinical Laboratory Standard, Wayne, PA, USA, 1998

Acknowledgements

The authors thank the Management and the authorities of Karunya University, Coimbatore, for their kind support, constant encouragement and also for providing KSJF fellowship to PR. Our thanks are also extended to SAIF, IIT, Madras, India and SAIF, IISC, Bangalore, India for NMR and Mass spectral analysis.

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg
AI Summary AI Mindmap
PDF(608 KB)

Accesses

Citations

Detail

Sections
Recommended

/